Myelin abnormalities exist in schizophrenia leading to the hypothesis that oligodendrocyte dysfunction plays a role in the pathophysiology of the disease. The expression of the mRNA for the peripheral myelin protein-22 (PMP-22) is decreased in schizophrenia and recent genetic evidence suggests a link between PMP-22 and schizophrenia. While PMP-22 mRNA is found in both rodent and human brain it has been generally thought that no protein expression occurs. Here we show that PMP-22 protein is present in myelin isolated from adult mouse and human brain. These results suggest that PMP-22 protein likely plays a role in the maintenance and function of central nervous system (CNS) myelin and provide an explanation for why altered PMP-22 expression may be pathophysiologically relevant in a CNS disorder such as schizophrenia. 
Introduction
Multiple lines of evidence including molecular studies, neuroimaging, as well as histopathological and ultrastructural analyses have demonstrated myelin abnormalities in schizophrenia, leading to the hypothesis that oligodendrocyte dysfunction plays a central role in its pathophysiology (reviewed in [1, 2] ). In particular, both microarray and quantitative polymerase chain reaction studies showed that expression of a subset of myelin-related genes is decreased in postmortem brain in schizophrenia [3] [4] [5] [6] [7] . Peripheral myelin protein-22 (PMP-22) is one of the myelin-related genes whose RNA is decreased in schizophrenia [4, 6] . Both a copy number variation in PMP-22 as well as a deletion in chromosome 17p12 which contains the PMP-22 gene have been linked to schizophrenia [8] .
PMP-22 is a transmembrane protein whose expression is most abundant in compact myelin of the peripheral nervous system (PNS) [9] where it is important for the establishment and maintenance of myelin [10] . The gene has two alternatively spliced forms containing either exon 1A or 1B, respectively, which are regulated by use of an alternative promoter with form 1A being myelin-specific, whereas form 1B is expressed more broadly [11] . As both exons 1A and B are non-coding, the two forms produce the same protein.
PMP-22 was initially identified as growth arrest specific gene 3 (gas 3) and subsequently as a protein whose expression is severely decreased post-peripheral nerve injury [12] .
PMP-22 mRNA is detected in both rodent [9, 13] and human brain [14] where relatively high levels of expression are found in the corpus callosum by Northern blotting. However, no protein expression has been detected in Western blots of total brain homogenates [9, 13] .
Recently it was suggested that the lack of PMP-22 protein expression in the CNS, despite the presence of RNA, results from the fact that in developing oligodendrocytes translation of PMP-22 RNA is negatively regulated by the microRNA mir-9 [15] . Therefore, although present in PNS myelin, PMP-22 is not considered a component of CNS myelin.
Given the apparent lack of PMP-22 protein expression in the CNS, it was surprising that genetic studies identified a link between PMP-22 and schizophrenia [8] . This led us to reexamine whether PMP-22 protein is expressed in the CNS, particularly focusing on white matter. Here we show that PMP-22 protein is present in myelin isolated from adult mouse and human brain.
Experimental Procedures

Isolation of myelin
Myelin was prepared from 3-month old adult mouse brain by density gradient centrifugation The myelin membranes were collected at the interphase of the sucrose solutions and further purified by hypo-osmotic shock in TrisHCl buffer yielding a crude myelin extract. To obtain purified myelin, the sucrose gradient centrifugation and hypo-osmotic shock were repeated once more. For Western blot analysis the myelin fraction was solubilized in 62.5 mM Tris HCl pH 6.8, 10% glycerol, 3% sodium dodecyl sulfate (SDS). As a positive control, mouse sciatic nerves were dissected and extracts prepared as described in Amici et al. [17] . 
Western blotting
results and discussion
Initially, we studied PMP-22 expression in 3-month old mouse brain by Western blotting.
As shown in Figure 1A , the PMP-22 protein could not be detected in total brain homogenate even when 100 μg of total protein was analyzed. In comparison, PMP-22 expression was found in the crude myelin fraction isolated from total brain, although its levels were considerably lower than those found in the sciatic nerve ( Figure 1A) . To substantiate the expression of PMP-22 in CNS white matter, purified myelin fractions were subsequently prepared from total brain and forebrain and analyzed using two different polyclonal antibodies ( Figure 1B ).
As shown on the Western blot, PMP-22 protein expression was detected in myelin isolated from both regions.
We next determined whether PMP-22 could be detected in myelin from human 
